Invention Grant
US07767688B2 Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours
有权
嘧啶氨基苯甲酰胺化合物和伊马替尼联合用于治疗胃肠道间质瘤
- Patent Title: Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours
- Patent Title (中): 嘧啶氨基苯甲酰胺化合物和伊马替尼联合用于治疗胃肠道间质瘤
-
Application No.: US11915650Application Date: 2006-06-02
-
Publication No.: US07767688B2Publication Date: 2010-08-03
- Inventor: Leila Alland , Paul W Manley , Juergen Mestan
- Applicant: Leila Alland , Paul W Manley , Juergen Mestan
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Sandra Shim
- International Application: PCT/US2006/021307 WO 20060602
- International Announcement: WO2006/132930 WO 20061214
- Main IPC: A61K31/505
- IPC: A61K31/505
Abstract:
The invention provides a pharmaceutical combination comprising: a) a pyrimidylaminobenzamide compound, and b) imatinib. and a method for treating or preventing a proliferative disease, especially GIST, using such a combination.
Public/Granted literature
- US20080312252A1 Combination of Organic Compounds Public/Granted day:2008-12-18
Information query
